KCNH2 and glioblastoma: Mutations in or pharmacological blockade of the hERG channel can result in fatal arrhythmias stemming from altered channel function.[43] In GBM, increased expression of hERG correlated with worse survival in a tissue microarray whilst patients treated with inhibitors of hERG showed better survival than those who did not.